Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Frequency and Genetic Determinants of Tigecycline Resistance in Clinically Isolated Stenotrophomonas maltophilia in Beijing, China.

Zhao J, Liu Y, Liu Y, Wang D, Ni W, Wang R, Liu Y, Zhang B.

Front Microbiol. 2018 Mar 26;9:549. doi: 10.3389/fmicb.2018.00549. eCollection 2018.

2.

Clinical Features, Antibiotic Susceptibility Profile, and Outcomes of Infectious Keratitis Caused by Stenotrophomonas maltophilia.

Palioura S, Gibbons A, Miller D, OʼBrien TP, Alfonso EC, Spierer O.

Cornea. 2018 Mar;37(3):326-330. doi: 10.1097/ICO.0000000000001486.

PMID:
29408828
3.

Micro-Patterned Surfaces That Exploit Stigmergy to Inhibit Biofilm Expansion.

Gloag ES, Elbadawi C, Zachreson CJ, Aharonovich I, Toth M, Charles IG, Turnbull L, Whitchurch CB.

Front Microbiol. 2017 Jan 23;7:2157. doi: 10.3389/fmicb.2016.02157. eCollection 2016.

4.

A Decade-Long Commitment to Antimicrobial Resistance Surveillance in Portugal.

Marinho CM, Santos T, Gonçalves A, Poeta P, Igrejas G.

Front Microbiol. 2016 Oct 31;7:1650. eCollection 2016. Review.

5.

Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options.

Chang YT, Lin CY, Chen YH, Hsueh PR.

Front Microbiol. 2015 Sep 2;6:893. doi: 10.3389/fmicb.2015.00893. eCollection 2015. Review.

6.

Magnitude of enterococcal bacteremia in trauma patients admitted for intensive trauma care: a tertiary care experience from South asian country.

Rajkumari N, Mathur P, Thanbuana B, Sajan S, Misra MC.

J Lab Physicians. 2015 Jan-Jun;7(1):38-42. doi: 10.4103/0974-2727.151699.

7.

Colonization, competition, and dispersal of pathogens in fluid flow networks.

Siryaporn A, Kim MK, Shen Y, Stone HA, Gitai Z.

Curr Biol. 2015 May 4;25(9):1201-7. doi: 10.1016/j.cub.2015.02.074. Epub 2015 Apr 2.

8.

Insights into cross-kingdom plant pathogenic bacteria.

Kirzinger MW, Nadarasah G, Stavrinides J.

Genes (Basel). 2011 Nov 28;2(4):980-97. doi: 10.3390/genes2040980.

9.
10.

Effects of small intestinal submucosa (SIS) on the murine innate immune microenvironment induced by heat-killed Staphylococcus aureus.

Roy Chowdhury R, Aachoui Y, Ghosh SK.

PLoS One. 2012;7(11):e48724. doi: 10.1371/journal.pone.0048724. Epub 2012 Nov 26.

11.

Structural features and kinetic characterization of alanine racemase from Staphylococcus aureus (Mu50).

Scaletti ER, Luckner SR, Krause KL.

Acta Crystallogr D Biol Crystallogr. 2012 Jan;68(Pt 1):82-92. doi: 10.1107/S0907444911050682. Epub 2011 Dec 9.

12.

A novel eukaryote-made thermostable DNA polymerase which is free from bacterial DNA contamination.

Niimi H, Mori M, Tabata H, Minami H, Ueno T, Hayashi S, Kitajima I.

J Clin Microbiol. 2011 Sep;49(9):3316-20. doi: 10.1128/JCM.00584-11. Epub 2011 Jul 20.

13.

Blechnum orientale Linn - a fern with potential as antioxidant, anticancer and antibacterial agent.

Lai HY, Lim YY, Kim KH.

BMC Complement Altern Med. 2010 Apr 30;10:15. doi: 10.1186/1472-6882-10-15.

14.

Development and evaluation of oligonucleotide chip based on the 16S-23S rRNA gene spacer region for detection of pathogenic microorganisms associated with sepsis.

Kim CM, Song ES, Jang HJ, Kim HJ, Lee S, Shin JH, Kim SJ, Jeong SH, Jeong J, Koh K, Choi GE, Lee EY, Chang CL.

J Clin Microbiol. 2010 May;48(5):1578-83. doi: 10.1128/JCM.01130-09. Epub 2010 Mar 17.

15.

Empirical antibiotics use in soft tissue infections.

Shortt R, Thoma A.

Can J Plast Surg. 2008 Winter;16(4):201-4.

16.

Diagnosis of bacteremia in whole-blood samples by use of a commercial universal 16S rRNA gene-based PCR and sequence analysis.

Wellinghausen N, Kochem AJ, Disqué C, Mühl H, Gebert S, Winter J, Matten J, Sakka SG.

J Clin Microbiol. 2009 Sep;47(9):2759-65. doi: 10.1128/JCM.00567-09. Epub 2009 Jul 1.

17.

Identification of human pathogens isolated from blood using microarray hybridisation and signal pattern recognition.

Wiesinger-Mayr H, Vierlinger K, Pichler R, Kriegner A, Hirschl AM, Presterl E, Bodrossy L, Noehammer C.

BMC Microbiol. 2007 Aug 14;7:78.

18.

A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate.

Russo TA, Beanan JM, Olson R, Genagon SA, MacDonald U, Cope JJ, Davidson BA, Johnston B, Johnson JR.

Vaccine. 2007 May 10;25(19):3859-70. Epub 2007 Feb 5.

19.

Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli.

Durant L, Metais A, Soulama-Mouze C, Genevard JM, Nassif X, Escaich S.

Infect Immun. 2007 Apr;75(4):1916-25. Epub 2006 Dec 4.

20.

Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam.

Breedt J, Teras J, Gardovskis J, Maritz FJ, Vaasna T, Ross DP, Gioud-Paquet M, Dartois N, Ellis-Grosse EJ, Loh E; Tigecycline 305 cSSSI Study Group.

Antimicrob Agents Chemother. 2005 Nov;49(11):4658-66.

Supplemental Content

Support Center